<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02150434</url>
  </required_header>
  <id_info>
    <org_study_id>FreeO2-Rehab-1</org_study_id>
    <nct_id>NCT02150434</nct_id>
  </id_info>
  <brief_title>Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD</brief_title>
  <acronym>FreeO2rehab</acronym>
  <official_title>Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canada Foundation for Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study was to evaluate a new system (FreeO2) that automatically
      titrates oxygen flow to maintain stable SpO2, in patients with moderate or severe chronic
      obstructive pulmonary disease during exercise. The investigators hypothesized that continuous
      automatic adjustment of the oxygen flows during exercise would better maintain patients
      within the oxygenation target, reduce episodes of desaturation and hyperoxia and would
      improve walking exercise tolerance in comparison with fixed levels of low-flow oxygen and
      with compressed air breathing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time within predefined SpO2 target</measure>
    <time_frame>during exercise (Endurance shuttle walking test)</time_frame>
    <description>The primary outcome of the study was the percentage of exercise time during which patients were kept within the SpO2 target of 92 to 96%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise tolerance</measure>
    <time_frame>duration of ESWT</time_frame>
    <description>Endurance shuttle walking test time and distance</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physiological parameters</measure>
    <time_frame>during ESWT</time_frame>
    <description>Physiological parameters continuously recorded by the FreeO2 system (SpO2, end-tidal CO2 [EtCO2], respiratory rate, heart rate and oxygen flow when automated oxygen titration was activated), blood gases (before and after ESWT and after recovery) and dyspnea assessment during ESWT with a 10-point Borg scale</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>COPD</condition>
  <condition>Exercise</condition>
  <condition>Endurance Shuttle Walking Test (Exercise at 85% of Maximal Shuttle Walking Test)</condition>
  <arm_group>
    <arm_group_label>Compressed Air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>compressed air delivered at a fixed flow of 2 L/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen constant flow</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oxygen delivered at a fixed flow of 2L/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automated oxygen titration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oxygen at a variable flows delivered by the FreeO2</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated oxygen titration</intervention_name>
    <description>Automated oxygen titration every second to maintain stable SpO2 at a predefined value (94% in the present study)</description>
    <arm_group_label>Automated oxygen titration</arm_group_label>
    <other_name>FreeO2 system TM, Oxy'nov.inc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Compressed air</intervention_name>
    <description>compressed air delivered at a fixed flow of 2 L/min</description>
    <arm_group_label>Compressed Air</arm_group_label>
    <other_name>Air</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen constant flow</intervention_name>
    <description>oxygen delivered at a fixed flow of 2L/min</description>
    <arm_group_label>Oxygen constant flow</arm_group_label>
    <other_name>Oxygen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 40 years

          -  Moderate to severe COPD according to the Global Initiative for Chronic Obstructive
             Lung Disease guidelines

          -  Who did not require long-term oxygen therapy were included in the study.

          -  Patients were also selected on the basis of known (end-exercise SpO2 &lt; 90% on a
             previous exercise test) or suspected (SpO2 &lt; 95% at rest) desaturation during exercise

        Exclusion Criteria:

          -  Episode of exacerbation or hospitalisation within last four weeks

          -  Current medical condition that could influence exercise tolerance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Lellouche, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche de l'IUCPQ</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <last_update_submitted>May 28, 2014</last_update_submitted>
  <last_update_submitted_qc>May 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oxygen therapy</keyword>
  <keyword>Hypoxemia</keyword>
  <keyword>COPD</keyword>
  <keyword>Closed-loop</keyword>
  <keyword>Automated titration,</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

